PRESS RELEASE Companies made unsupported claims that their oils, balms, gummies, coffee, and other goods could treat serious diseases such as cancer and diabetes The Federal Trade Commission today announced the first law enforcement crackdown on deceptive claims in the growing market for cannabidiol (CBD) products. The FTC is taking action against six sellers of […]
Federal Trade Commission (FTC)
Federal Antitrust Scrutiny and (Certain) Cannabis Deal
By Hilary Bricken, Co-Founder Harris Bricken If you follow state-by-state legal cannabis legalization, you’re aware that despite the federal illegality of cannabis, certain federal agencies police the cannabis industry like they do any other legal industry. For example, the NLRB has been known to go after cannabis companies engaged in hostile workplace conduct and the […]
VDACS Okays Manufacture of CBD Products Intended for Human Consumption
The Virginia Department of Agriculture and Consumer Services (“VDACS”) Commissioner Jewel Bronaugh sent a letter (the “July Letter”) to all Virginia-registered Industrial Hemp Processors (“Processors”) on July 15, 2019 notifying the Processors that Governor Northam’s office has directed VDACS to “treat hemp-derived extracts intended for human consumption as approved food additives and to place qualifying […]
FDA Updates Guidance for CBD Products amid a New Round of Warning Letters and Announcement of Date for Public Hearing
By Ian Stewart & Neil Willner Attorneys at Wilson Elser On April 2, 2019, the U.S. Food and Drug Administration (FDA) issued a sweeping press release from outgoing Commissioner Scott Gottlieb covering new steps to advance the agency’s continued evaluation of potential regulatory pathways for CBD products. The five-page statement outlined what the FDA has […]
